QC
BMY icon

Quent Capital’s Bristol-Myers Squibb BMY Stock Holding History

Quent Capital’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$156K Sell
2,566
-419
-14% -$24.4K 0.01% 439
2025
Q4 		$161K Buy
2,985
+666
+29% +$32K 0.01% 436
2025
Q3 		$105K Buy
+2,319
New +$108K 0.01% 422
2025
Q2 		– Sell
-1,676
Closed -$102K – 403
2025
Q1 		$102K Sell
1,676
-738
-31% -$43K 0.01% 390
2024
Q4 		$137K Buy
2,414
+56
+2% +$3.13K 0.01% 339
2024
Q3 		$122K Sell
2,358
-590
-20% -$27.7K 0.01% 445
2024
Q2 		$122K Sell
2,948
-1,023
-26% -$45.8K 0.01% 417
2024
Q1 		$215K Sell
3,971
-525
-12% -$26.7K 0.03% 308
2023
Q4 		$231K Sell
4,496
-936
-17% -$49.1K 0.03% 284
2023
Q3 		$315K Sell
5,432
-649
-11% -$39.8K 0.05% 204
2023
Q2 		$389K Buy
6,081
+866
+17% +$58.1K 0.06% 187
2023
Q1 		$361K Buy
5,215
+181
+4% +$12.8K 0.06% 191
2022
Q4 		$362K Buy
5,034
+281
+6% +$21.2K 0.07% 190
2022
Q3 		$338K Buy
4,753
+660
+16% +$47.9K 0.07% 176
2022
Q2 		$315K Buy
4,093
+330
+9% +$25.1K 0.07% 167
2022
Q1 		$275K Buy
3,763
+211
+6% +$14.2K 0.05% 222
2021
Q4 		$222K Buy
+3,552
New +$208K 0.05% 269

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Quent Capital's BMY Position: Q1 2026 in Review

Quent Capital reduced its Bristol-Myers Squibb (BMY) stake by 14% in Q1 2026, selling an estimated $24.4K and leaving 2,566 shares worth $156K. The position accounts for 0.01% of the portfolio, ranked #439.

Quent Capital first reported a position in BMY in Q4 2021 and has held it in 17 quarters since. The position peaked at $389K in Q2 2023. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Quent Capital held 2,566 shares of Bristol-Myers Squibb worth $156K as of Q1 2026.
  • Quent Capital sold 419 Bristol-Myers Squibb shares in Q1 2026, an estimated $24.4K.
  • Bristol-Myers Squibb made up 0.01% of Quent Capital's portfolio in Q1 2026, its #439 holding.
  • Quent Capital first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 17 quarters since.
  • Quent Capital's Bristol-Myers Squibb position peaked at $389K in Q2 2023.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.